Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Upfront & milestone payments received for out-licensed by Year
Upfront & milestone payments received for out-licensed products — Worldwide ($M) ($M)
Merck Upfront & milestone payments received for out-licensed: $138M in FY2025, up 30.2% from a year earlier.
Where the FY2025 figure comes from
“out-licensed products were $138 million and $106 million”
Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Reported in Form 8-K Table 3 Footnote (Upfront and milestone payments received for out-licensed products).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Upfront & milestone payments received for out-licensed products — Worldwide ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 138 | +30.2% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2024 | Dec 31, 2024 | 106 | -10.2% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 118 | – | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
Cite this data
StockData. (2026). Merck Upfront & milestone payments received for out-licensed ($M), annual FY2023–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-outlicensed-milestones
See every metric in the Merck KPI table. Data updated Oct 26, 2026.